Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
![]()
GlycoCheck’s single overall health score quantifies the differences between a healthy and unhealthy circulatory system due to deterioration of the endothelial glycocalyx
Share this Article:
Tweet
|
Company
GlycoCheck and Microvascular Health Solutions
Headquarters
Alpine, UT
Management
Robert Long, Co-Founder & CEO; and Dr. Hans Vink, Co-Founder & Chief Science Officer
Description
GlycoCheck and Microvascular Health Solutions creates and delivers medical devices and nutritional supplements that monitor and support the health and well-being of the endothelial glycocalyx and the microvascular system. The company’s flagship product is the GlycoCheck, a clinically-validated, class-one medical device that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx. With the revolutionary patented imaging software and hardware system, healthcare professionals can identify and monitor the contribution of microvascular dysfunction and glycocalyx damage during disease development. Microvascular Health Solutions has also developed a game-changing, proprietary, patented anti-aging supplement Endocalyx, which delivers the anti-aging building blocks essential to maintaining a healthy endothelial glycocalyx and capillaries in the microvascular system. This unique combination of GlycoCheck, the Microvascular Health Score, and the Endocalyx nutraceutical has proven to be successful in restoring, regenerating, and protecting the glycocalyx gel lining of the microvascular system in order to prevent organ starvation
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info